drugset / Trial / NCT00234676
POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson's Disease
Phase 2
Completed
23 enrolled
The Parkinson Study Group
Joseph and Rosalyn Newman Foundation · collabWyeth is now a wholly owned subsidiary of Pfizer · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objectives of the POETRY study are to assess the safety and tolerability of estrogen replacement therapy (ERT) in postmenopausal women with Parkinson's disease (PD) and to assess recruitment for a study of ERT in postmenopausal women with PD.
Timeline
- Start
- 2003-10
- Primary completion
- 2006-03
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ESTROGENS, CONJUGATED | Unknown | 0.625 mg | Oral |